BioMarin's has signed the first contract with an insurer in Germany for Roctavian, its recently approved gene therapy for haemophilia A, as it tests out its outcomes-based agreement (OBA) ...
BioMarin Pharma has decided not to divest its haemophilia A gene therapy Roctavian, which has struggled to build much traction in the market, but is reining back its ambitions for the business. The ...
In 43 B.C., Mark Antony murdered Cicero, famous for his unparalleled powers of speech, and ushered in the beginnings of the Roman Empire. Lawyer, Statesman, PhilosopherCicero is remembered for his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback